BioSpace News Archive

Medtronic plc announced financial results for its first quarter of fiscal year 2024, which ended July 28, 2023.

BioLineRx Ltd. announced today it will release its unaudited financial results for the quarter ended June 30, 2023 on Wednesday, August 30, 2023, before the U.S. markets open.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

AstriVax is pleased to announce that Dr. Christian Brander and Dr. Mala Maini have agreed to join the company’s scientific advisory board.

Berlin Heals Holding AG, a Swiss medical technology company, is delighted to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the Board of Directors.

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announces the commercial launch of ColoAlert® in Poland, made possible through a strategic collaboration with testDNA Sp. z o. o. Sp. K.

Actimed Therapeutics Ltd announces it has raised a further £4.75m in an extension to its recent Series A financing round which was completed in June this year.

BerGenBio ASA announced that additional clinical data of bemcentinib in combination with chemotherapy and with immunotherapy in Non-Small Cell Lung Cancer have been recently published and accepted for presentation at two upcoming international oncology conferences.

Kintor Pharmaceutical Limited announced that the company has completed the enrollment of 180 patients for the Phase II clinical trial of its in-house developed first-in-class proteolysis targeting chimera compound GT20029 in China for the treatment of male androgenetic alopecia.

Shoulder Innovations Inc., a Grand Rapids, Michigan-based leader in the shoulder replacement implant market, announced securing of a $45M debt facility in partnership with Trinity Capital.